Fund
Pureos Bioventures
Pureos Bioventures followed on in the round of AnaCardio (62,5 M€, Series B) on 30 September 2026. It is the only health round Bolus has logged for it so far.
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 1
- Lead
- 0
- New entries
- 0
- Follow ons
- 1
- Latest operation
- 30 September 2026
- Sectors
- Biotech
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 30 Sept | Sweden, Biotech | Series B | 62,5 M€ | Existing investor |
Co investors 8 funds crossed
- Flerie 1 operation
- Helsinn 1 operation
- Industrifonden 1 operation
- Innovestor Life Science 1 operation
- Ljungström family office 1 operation
- LLD Nybohov Invest AB 1 operation
- Novo Holdings 1 operation
- Sound Bioventures 1 operation
Funds that appeared in the same rounds, in any capacity. Geographies logged: Sweden.